Study of Cingal™ for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide

Summary

This is a multi-center, randomized, double-blind, parallel group, active comparator controlled trial to evaluate the efficacy and safety of a single injection of Cingal for the relief of joint pain in subjects with OA of the knee.

Timeline

Start

2017-05-25

Primary completion

2018-04-23

Completion

2018-04-23

Outcome

Missed primary endpoint

registry analysis (superiority test); Cingal vs Triamcinolone Hexacetonide (TH); p = 0.5874; ANOVA NCT03191903 ↗

Drugs

Indications